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IKKβ overexpression together with a lack of tumour
suppressor genes causes ameloblastic odontomas in mice
Angustias Page1,2,3, Ana Bravo 4, Cristian Suarez-Cabrera1,2, Raquel Sanchez-Baltasar 1,2, Marta Oteo5, Miguel Angel Morcillo5,
M. Llanos Casanova1,2,3, Jose C. Segovia 6,7, Manuel Navarro 1,2,3 and Angel Ramirez 1,2,3
Odontogenic tumours are a heterogeneous group of lesions that develop in the oral cavity region and are characterized by the
formation of tumoural structures that differentiate as teeth. Due to the diversity of their histopathological characteristics and clinical
behaviour, the classification of these tumours is still under debate. Alterations in morphogenesis pathways such as the Hedgehog,
MAPK and WNT/β-catenin pathways are implicated in the formation of odontogenic lesions, but the molecular bases of many of
these lesions are still unknown. In this study, we used genetically modified mice to study the role of IKKβ (a fundamental regulator
of NF-κB activity and many other proteins) in oral epithelial cells and odontogenic tissues. Transgenic mice overexpressing IKKβ in
oral epithelial cells show a significant increase in immune cells in both the oral epithelia and oral submucosa. They also show
changes in the expression of several proteins and miRNAs that are important for cancer development. Interestingly, we found that
overactivity of IKKβ in oral epithelia and odontogenic tissues, in conjunction with the loss of tumour suppressor proteins (p53, or
p16 and p19), leads to the appearance of odontogenic tumours that can be classified as ameloblastic odontomas, sometimes
accompanied by foci of secondary ameloblastic carcinomas. These tumours show NF-κB activation and increased β-catenin activity.
These findings may help to elucidate the molecular determinants of odontogenic tumourigenesis and the role of IKKβ in the
homoeostasis and tumoural transformation of oral and odontogenic epithelia.
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INTRODUCTION
The IKK complex is responsible for the regulation of the NF-κB
family of transcription factors, which regulates genes associated
with cell survival and increased proliferation. Deregulated NF-κB
activation underlies disease states in many organs, including
chronic inflammation and cancer. The IKK complex is formed by
two catalytic subunits with kinase activity (IKKα and IKKβ) and one
regulatory subunit (IKKγ or NEMO).1 In addition to the role of IKKβ
as a positive regulator of NF-κB activity, it interacts with,
phosphorylates, and thereby modifies the activity of a plethora
of proteins implicated in a number of functions.1,2 Furthermore, it
has recently been reported that the IKK complex acts as a general
regulator of gene expression by modifying mRNA stability.3 Thus,
IKKβ is able to regulate cellular physiology in different ways and,
not surprisingly, changes in the activity of IKKβ are associated with
cancer in several cell types. Interestingly, IKKβ can either promote
or prevent tumour development, depending on the cell type and
other circumstances that are not yet well understood, probably
due to the large number of proteins regulated by this kinase.4
Previously, we generated transgenic mice overexpressing IKKβ
in basal cells of the stratified epithelia and in exocrine glands. In
addition to other phenotypes, IKKβ overexpression in these mice
led to greater numbers of CD45+ haematopoietic cells as well as
granulocytes (Gr-1+), macrophages (F4/80+) and B cells (B220+) in
the forestomach epithelium5 and to the development of super-
numerary teeth due to reduced apoptosis and upregulation of the
WNT signalling pathway in the embryonic incisor bud epithelium
of K5-IKKβ mice.6 Carcinogenesis experiments performed in a
genetic background prone to tumour development through the
expression of an active form of RAS revealed that K5-IKKβmice are
resistant to skin cancer,7 but they develop more malignant
tumours than control littermates in the forestomach and the
palate.5 In the course of these experiments, we crossed the K5-
IKKβ transgene into backgrounds lacking p53 in epithelial cells
(p53EKO/K5-IKKβ mice) or lacking p16 and p19 in every cell (Ink4a/
Arf KO/K5-IKKβ). Surprisingly, a high percentage of these mice
developed spontaneous odontogenic tumours.
Odontogenic tumours are a heterogeneous group of lesions of
the oral cavity that result in the formation of tumoural structures
that differentiate as teeth. Their classification is still under debate
and has been recently modified by the World Health Organiza-
tion.8 These lesions are currently classified as odontogenic cysts
and odontogenic tumours (benign or malignant), and each of
these categories is in turn classified into a number of
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subcategories. Although the aetiology of these tumours is
unknown in many cases, activating mutations in the Hedgehog
(mutations in SMO and PTCH1) and mitogen-activated protein
kinase (MAPK; mutations in BRAF, RAS, PIK3CA or FGFR2) pathways
have been identified in benign and malignant odontogenic
tumours. Other genetic alterations found in odontogenic tumours
are associated with the WNT pathway (in APC, MCC and CTNNB1)
and other genes that are commonly mutated in cancer (i.e.,
CDKN2A or TP53).8 In addition, epigenetic alterations have been
described in these tumours.9
Transgenic mice in which WNT signalling is activated through
the expression of stabilized forms of β-catenin in oral epithelia
resulted in the development of supernumerary teeth.10,11
Although these animal models do not survive postnatally,
precluding the study of tumour formation in adulthood, the
alterations that they develop resemble odontogenic tumours.
Postnatal activation of the WNT pathway in dental stem cells
results in odontoma formation.12 However, other determinants of
odontogenic tumours are still unknown, and there is a need for
additional animal models to reveal the genetic diversity under-
lying odontogenic tumours.
Here, we analyse the effect of IKKβ overexpression in epithelial
cells of the gingiva and palate and the inflammatory disease
caused by IKKβ in the oral epithelia as well as the associated
changes in the expression of several key proteins and miRNAs that
are important for cancer development. We demonstrate that the
overactivity of IKKβ in oral epithelial cells and odontogenic tissues,
in conjunction with the loss of tumour suppressor proteins (p53,
or p16 and p19), leads to the appearance of odontogenic tumours.
Molecular characterization of these tumours indicates that they
show NF-κB activation and increased β-catenin activity. These
findings shed some light on the role of IKKβ in the homoeostasis
and tumoural transformation of oral and odontogenic epithelia.
RESULTS
Chronic inflammation of oral epithelia in K5-IKKβ transgenic mice
Previously, we reported that K5-IKKβ transgenic mice develop
histologic and inflammatory alterations in both the palate and the
non-glandular stomach, which could underlie their predisposition
to develop tumours in the oral epithelia.5 With the aim of
understanding the role played by IKKβ in the oral epithelia, we
studied these organs in K5-IKKβ mice in depth. In in vitro studies
with cultured oral keratinocytes, K5-IKKβ cells showed more
proliferation (measured as BrdU incorporation) and fewer
senescent cells (measured as senescence-associated β-gal activity)
than cultured wild-type (wt) oral keratinocytes (Supplementary
Figs. 1, 2); in addition, K5-IKKβ oral keratinocytes formed a greater
number of colonies (though smaller in size) when seeded at low
density (Supplementary Fig. 3), although they were not fully
transformed, as they were not able to grow when injected
subcutaneously into nude mice (not shown). Next, we studied the
infiltrating populations in both the epithelium and the submucosa
of the palate by flow cytometry (Fig. 1a, b). Interestingly,
approximately 10% of the cells from the epithelia of wt mice
and 6.6% from the submucosa were not of epithelial origin but
were infiltrating haematopoietic (CD45+) cells. Almost half of
these cells could be classified as either macrophages or T-
lymphocytes based on the labelling obtained with CD11b (also
known as Mac-1) and CD3 antibodies, and some of these T-cells
were of the γδ subtype, similar to the dendritic epidermal T cells
residing in the skin. Interestingly, epithelial IKKβ overexpression in
transgenic (tg) mice led to a large (statistically significant) increase
in haematopoietic CD45+ cells in the palate epithelia, where
haematopoietic infiltrating cells represented more than half of the
total cell number (Fig. 1b). The increases in epithelial macrophages
and oral dendritic cells were also noticeable and statistically
significant in the palate epithelium of tg mice in comparison to wt.
Additionally, we found a modest but statistically non-significant
increase in these cell types in the oral submucosa (Fig. 1b).
Immunohistochemical staining of palate sections verified the
overexpression of IKKβ (Fig. 1c, g; arrowheads) and the presence
of more CD45+ and CD11b+ cells in transgenic samples (Fig. 1d, e,
h, i; arrows).
Alterations in the expression of tumour suppressor proteins and
microRNAs in K5-IKKβ oral keratinocytes
We next studied the expression levels of several genes and
microRNAs (miRNAs) that are important for tumour develop-
ment in cultured oral epithelial cells from wt and tg mice with
IKKβ overexpression. K5-IKKβ oral keratinocytes showed
increased phosphorylation of Ser536 of p65, indicative of NF-κB
activation (Fig. 1k). Interestingly, in contrast to the increased
expression of p16, p19 and p53 found in murine skin
keratinocytes overexpressing IKKβ,7 oral keratinocytes over-
expressing IKKβ expressed lower levels of these tumour
suppressor proteins (Fig. 1k), suggesting that the pathways
modified by IKKβ in oral and skin keratinocytes are at least
partially different. Reduced expression was confirmed at the
mRNA level for p19, but not for p16 and p53, suggesting the
involvement of some mechanism of posttranscriptional regula-
tion (in fact, we observed an increase in the level of p53 mRNA;
Fig. 1l). Immunohistochemical studies confirmed the lower
expression of p19 in K5-IKKβ oral epithelial cells in vivo, where
most of the nuclei of the basal layers were negative for
p19 staining (Fig. 1f, j). In summary, we have found that
overexpression of IKKβ in oral epithelial cells leads to decreased
expression of several tumour suppressor proteins.
To characterize the expression of other important players in
tumoural transformation, we studied the expression of several
microRNAs previously described to be altered in cancer (Fig. 1m).
K5-IKKβ oral keratinocytes expressed substantially lower amounts
of several members of the let-7 group, miR-125b, miR-21 and miR-
34c than wt oral keratinocytes. Interestingly, let-7 family members,
miR-125b and miR-34 tend to be downregulated in tumoural
samples, including those from the oral cavity.13–16 In summary, K5-
IKKβ oral epithelial cells presented lower levels of a number of
miRNAs that are usually downregulated in transformed states. In
contrast, we did not observe a decrease in miR-203, which is
another microRNA whose downregulation is usually associated
with tumoural transformation, nor a significant difference for miR-
205 (Fig. 1m).
Loss of tumour suppressor proteins led to spontaneous
odontogenic tumours in K5-IKKβ transgenic mice
In the context of our study on the role of IKKβ in skin cancer, we
generated cohorts of K5-IKKβ transgenic mice that also lacked
either p53 in stratified epithelial tissues (p53EKO/K5-IKKβ mice) or
p16 and p19 in every cell (Ink4a/Arf KO/K5-IKKβmice). Interestingly,
in addition to an Ink4a/Arf-dependent antitumoural role of IKKβ in
skin cancer,7 we observed that overexpression of IKKβ in the
absence of either epithelial p53 or both p16 and p19 led to the
appearance of maxillary tumours (usually monolateral) that caused
facial distortion and swelling in some mice (Fig. 2a, b). These
tumours appeared as radiopaque protuberant masses that
expanded past the natural snout line and were associated with
bone loss (Fig. 2c, d). We did not observe any odontogenic
tumours in mice lacking the K5-IKKβ transgene, independently of
the p53 or p16/p19 genetic background, or in K5-IKKβ mice
bearing wt copies of p53 and Ink4a/Arf (Fig. 2e, f). By contrast,
p53EKO/K5-IKKβ and Ink4a/Arf KO/K5-IKKβ mice developed similar
odontogenic tumours at frequencies of 13.6% and 34.4%,
respectively (Table 1). These differences in the distribution of
odontogenic tumours in mice bearing and lacking the K5-IKKβ
transgene were statistically significant (P < 0.0001, Fisher exact
test). We did not observe differences between the sexes in the
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incidence of odontogenic tumours in either p53EKO/K5-IKKβ or
Ink4a/Arf KO/K5-IKKβ mice.
Histological examination of these tumours revealed charac-
teristics of ameloblastic odontomas (or odontoameloblastomas)
that agreed with the international classification of dental
tumours in mice.17 The ameloblastic odontomas of both
p53EKO/K5-IKKβ and Ink4a/Arf KO/K5-IKKβ mice appeared as
well-circumscribed tumours that showed differentiation into
hard dental tissues, normally located in the central areas of the
tumour, and soft tissues composed of proliferating ameloblastic
epithelium, generally located at the periphery of the tumour
(Fig. 2g–j). The hard tissues of the tumours showed different
degrees of morphologic differentiation of tooth structures,
ranging from primitive tooth buds (denticles; open arrows in
Fig. 2g, h) to mature teeth with distinct ameloblasts, odonto-
blasts, dentin-like and enamel-like material and cementum (Fig.
2g, open arrowhead). The inner areas of these tooth structures
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Fig. 1 IKKβ leads to changes in immune cell populations and the expression of relevant proteins and miRNAs in cancer in oral epithelia. a
Examples of flow cytometry plots showing the increase in CD45+ cells in both the oral epithelium and oral submucosa in K5-IKKβ transgenic
mice compared to wt littermates. b Frequency of CD45, CD11b, CD3 and γδT cells in the oral epithelium and submucosa of animals of the
indicated genotypes. c–j Immunohistochemical staining for IKKβ, CD45, CD11b and p19 in palate sections in wt (c–f) and K5-IKKβ mice (g–j). k
Western blots for the indicated proteins in protein extracts from cultured oral keratinocytes. l RT-qPCR analysis of mRNAs for tumour
suppressor proteins. m RT-qPCR analysis of the indicated miRNAs in oral keratinocytes of the indicated genotypes. *P < 0.05; **P < 0.01. Bar:
100 μm.
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(Fig. 2g, asterisks). It was not rare to find multifocal areas of
haemorrhage (Fig. 2g, h, j white arrows), necrosis, inflammation
and poorly calcified new bone formation (Fig. 2g, h, j, yellow
arrowheads). Although ameloblastic odontomas usually do not
metastasize,17 the soft ameloblastic epithelium of the periphery
of the tumours that developed in both p53EKO/K5-IKKβ and
Ink4a/Arf KO/K5-IKKβ mice tended to form foci of highly
proliferative and hyperchromatic solid cellular masses (Fig. 2i, j,
white arrowheads) showing severe pleomorphism and abundant
mitosis, suggestive of the development of secondary ameloblastic
carcinoma (Fig. 2j, inset); these foci displayed local infiltration and
destruction of the alveolar bone (Fig. 2i, j, yellow arrows) and

















Fig. 2 Odontogenic tumours in K5-IKKβ mice lacking either p53 or the p16 and p19 tumour suppressor proteins. a–f Macroscopic and
computed tomography (CT) images of an Ink4a/Arf KO/K5-IKKβ mouse with an odontogenic tumour (a, c, d) and a wild-type mouse (b, e, f). a,
b External appearance of an Ink4a/Arf KO/K5-IKKβ mouse affected by an odontogenic tumour arising in the left maxilla (a) and a wild-type
mouse (b). c, e CT images of the heads of these mice. d, f Reconstructed 3D CT scan images of the skulls of these mice. The arrows indicate a
left maxilla deformity caused by the odontogenic tumour. g–j HE staining of histological sections from ameloblastic odontomas in p53EKO/
K5-IKKβ (g, h) and Ink4a/Arf KO/K5-IKKβ (i, j) mice. The tumours showed two components: hard tissues producing primitive denticles (bold
arrows in g, h) or mature tooth buds (arrowhead in g) containing stellate reticulum-like cells (asterisks in g) and soft tissues composed of
proliferating ameloblasts; these areas tended to form foci of secondary ameloblastic carcinoma (white arrowheads in i, j) that infiltrated and
destroyed the alveolar bone (yellow arrows in i, j). These malignant foci showed highly proliferative and hyperchromatic ameloblastic cells
that displayed severe pleomorphism and abundant mitosis, some of which were aberrant (inset in j). The tumours commonly showed
multifocal haemorrhages (white arrows in g, h, j) and new bone formation (yellow arrowheads in g, h, j). Compare the poorly calcified
eosinophilic new bone matrix (yellow arrowheads in g, h, j) with the mature mineralized basophilic alveolar bone (yellow arrows in i, j). Bar:
100 μm, except in the inset in j (33 μm).
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Odontogenic tumours derived from IKKβ-expressing cells showed
activation of proliferative pathways
We next immunohistochemically studied the expression of
epidermal and mesenchymal markers in odontogenic tumours
as well as the expression of proteins that are important in the
transduction of prosurvival and proliferation signals that are
frequently activated in cancer. The ameloblastic odontomas of
mice overexpressing IKKβ maintained the epithelial differentiation
of the soft ameloblastic epithelium, as it was mainly positive for
staining with an antibody specific for keratin K5 (Fig. 3a). The
ameloblastic regions of the tumours that expressed keratin K5 at
higher levels also showed detectable expression of IKKβ (Fig. 3b)
and increased activation of NF-κB, measured as staining for
phospo-p65 (Fig. 3c). Notably, the hard and internal portions of
the denticles (dentin, odontoblasts and stellate reticular cells) did
not express keratin K5 (Fig. 3a, d) or p63 (Fig. 3e) but were positive
for vimentin staining (Fig. 3f, arrowheads), indicating the
mesenchymal differentiation of these cells, as occurs in normal
teeth. The ameloblastic odontomas showed activation of the
canonical WNT/β-catenin, STAT3 and AKT signalling pathways in
the ameloblastic epithelium, as they exhibited nuclear β-catenin
and STAT3 staining, especially in the foci of secondary
ameloblastic carcinoma (insets in Fig. 3g, h), which were also
positive for staining with an antibody specific for phospho-AKT
(Ser473), an active form of AKT (Fig. 3i).
These results were confirmed by western blot analysis of
protein extracts from several odontogenic tumours. We analysed
three ameloblastic odontomas from Ink4a/Arf KO/K5-IKKβ and two
from the p53EKO/K5-IKKβ background as well as non-tumoural oral
and odontogenic tissues from the genotypes indicated in Fig. 4.
All the tumours (lanes 1–5) expressed higher levels of IKKβ than
the non-tumoural oral and dental tissues of K5-IKKβ (lanes 6–8) or
wild-type mice (lane 9). In addition, tumoural samples showed
increased levels of phospho-p65 and phospho-IκBα, indicative of
NF-κB activation, and increased expression (and, to a lesser extent,
phosphorylation) of AKT and STAT3 than non-tumoural samples.
Odontogenic tumours showed increased total and active
β-catenin as well. Interestingly, the tumoural samples also
expressed more MMP2; as MMP2 degrades type IV collagen, the
most abundant component of the basement membrane, its
overexpression could contribute to the aggressive local behaviour
and metastatic potential (see below) observed in the foci of
secondary ameloblastic carcinoma that developed in the pre-
existing ameloblastic odontomas. Notably, we only detected p19
Table 1. Spontaneous ameloblastic odontomas and other epithelial tumours in p53EKO/ K5-IKKβ, p53EKO, Ink4a/Arf KO/K5-IKKβ, and Ink4a/Arf KO mice.
Items p53EKO/K5-IKKβ p53EKO Ink4a/ArfKO/ K5-IKKβ Ink4a/ArfKO
Mice analysed 59 55 61 43
Mice with tumours 26 31 28 9
Number of epithelial tumours 35 46 28 2
Mice with ameloblastic odontomas 8 0 21 0
Number of ameloblastic odontomas 10 0 21 0
Ameloblastic odontomas vs. epithelial tumours/% 28.6 0 75.0 0
Mice with ameloblastic odontomas/% 13.6 0 34.4 0











Fig. 3 Immunohistochemical analyses of ameloblastic odontomas. a–i Immunohistochemical staining for keratin K5 (a, d), IKKβ (b), phospho-
p65 (c), p63 (e), vimentin (f), β-catenin (g), STAT3 (h) and phospho-AKT (i) are shown. Am ep, ameloblastic epithelia; De, dentin; Od,
odontoblasts. Bar: 100 μm, except in the insets in g and h (50 μm).
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in tumoural samples from animals with a wild-type Ink4a/Arf locus
(lanes 4–5).
In summary, the analyses of odontogenic tumours and non-
tumoural samples by immunohistochemistry and western blotting
indicated activation of the NF-κB, AKT, STAT3 and WNT/β-catenin
pathways in tumoural samples, independent of their genetic
background.
Odontogenic tumours in K5-IKKβ transgenic mice can metastasize
Ameloblastic odontomas are considered benign or low-grade
malignant neoplasias that usually do not metastasize but behave
as locally aggressive growths invading and destroying surround-
ing tissues, including bone.17 By contrast, the tumoural lesions
observed in K5-IKKβ mice simultaneously lacking p53 or p16 and
p19 were able to metastasize (Fig. 5). We observed metastasis to a
cervical lymph node, which was filled with cells similar to stellate
reticulum cells (Fig. 5a) in an Ink4a/Arf KO/K5-IKKβ mouse. In
another Ink4a/Arf KO/K5-IKKβ mouse, we found an ameloblastic
odontoma with foci of secondary ameloblastic carcinoma around
the denticles (Fig. 5b, arrowheads), which developed microscopic
metastatic foci in the lung, showing a cellular pattern similar to
secondary ameloblastic carcinoma with abundant areas of
squamous differentiation (Fig. 5c, arrows). The metastatic nature
of this lesion was confirmed by its positive immunohistochemical
staining for keratin K5, IKKβ and p63 (arrowheads in Fig. 5d–f).
From these results, we conclude that the ameloblastic odontomas
developed as a consequence of IKKβ overexpression in the
context of a lack of tumour suppressor proteins are able to evolve
into secondary ameloblastic carcinomas and metastasize to
regional lymph nodes and the lung.
DISCUSSION
IKKβ exerts its multiple functions by positively regulating the
activity of NF-κB but also via the phosphorylation and, hence,
regulation of a number of other substrates that are important in
multiple pathways affecting cell physiology.1,2 The role of IKKβ in
cancer is consequently complex, showing both tumour-promoting
and tumour-repressing activities, depending on the tissue and the
cellular context.4
NF-κB drives a proinflammatory pathway that is constitutively
activated and promotes invasion in oral squamous cell carcinomas
(SCC).18 In this report, we have characterized the frequency of









































Fig. 4 Western blot analysis of odontogenic tumours and non-
tumoural tissues from normal maxillae of the indicated genotypes.
Odontogenic tumours (lanes 1–5) showed increased expression of
IKKβ, increased NFκB activation and increased expression or activity
of the AKT, STAT3 and WNT/β-catenin pathways as well as increased
expression of MMP2 compared to non-tumoural oral and odonto-







Fig. 5 Metastasis from odontogenic tumours. a Metastasis observed in a cervical lymph node showing poorly differentiated ameloblasts and
stellate reticulum-like cells. b, c primary ameloblastic odontoma with foci of ameloblastic carcinoma (arrowheads in b) and microscopic
metastasis of the lung showing ameloblast proliferation with abundant foci of squamous metaplasia (arrows in c) in an Ink4a/Arf KO/K5-IKKβ
mouse. d–f Immunohistochemical staining of the same lung metastasis shown in c with the indicated antibodies; note that only proliferating
ameloblasts showed specific staining, while the foci of squamous metaplasia appeared unstained. Lu, lung tissue; Met, lung metastasis. Bar:
100 μm.
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type and K5-IKKβ transgenic mice. The presence of immune cells
in the oral mucosa is not surprising, as the oral cavity represents a
gate for the entry of microorganisms into the body. Notably,
approximately 10% of the cells in the oral epithelia of wild-type
mice are of immune origin (i.e., CD45+ cells). In addition, IKKβ
overexpression triggers a strong oral inflammatory response, as
the percentage of immune cells increases up to more than 50% of
the total cells in the oral epithelia. Accordingly, in the underlying
submucosa, there is also a marked inflammatory response,
although it is not as strong as in the oral epithelium. Some
ameloblastic carcinomas in humans have been proposed to
develop from ameloblastomas.19 Our results suggest that
increased IKKβ expression provokes NF-κB activation and a strong
inflammatory response that could contribute to the tumoural
transformation of the odontogenic epithelium through the
uncontrolled release of inflammatory cytokines and facilitate the
development of a secondary ameloblastic carcinoma in a pre-
existing ameloblastic odontoma, although the existence of other
driving factors cannot be ruled out.
miRNAs are small non-coding RNAs that regulate gene
expression by modifying the stability and transcription rate of
target messenger RNAs. Each miRNA usually regulates a number
of different targets and, hence, shows pleiotropic effects. Not
surprisingly, miRNA deregulation is an important player in cancer
pathogenesis, including oral SCC and head and neck cancer.15 The
miRNAs that were downregulated by IKKβ overexpression
included let-7b, let-7c, miR-125b, miR-21 and miR-34c; interest-
ingly, all of these miRNAs are functionally related to tumoural
transformation.
miRNAs of the let-7 family promote cellular differentiation and
are considered tumour suppressors. These miRNAs are frequently
expressed at low levels in human cancers and cancer stem cells.
Among their targets, there are several cancer genes, such as RAS,
MYC, HMGA2 and STAT3,20,21 and a negative feed-back loop
between let-7 members and β-catenin has been described.22
Therefore, the low levels observed for let-7b and let-7c could be
important in the development of ameloblastic odontomas and
secondary ameloblastic carcinomas in K5-IKKβ mice or, alterna-
tively, could be secondary to β-catenin overactivity.
Although the function of the miR-125 family is somewhat
controversial, its members are known to target several oncogenes,
transcription factors and growth factors, and its function is tumour
suppressive in a number of organs and tissues, including
ectodermal derivatives.23 miR-125b is downregulated in oral
SCC, and low expression of miR-125b contributes to head and
neck cancer development;14 moreover, the restoration of miR-
125b expression in oral SCC cell lines reduces the proliferation of
these cells.13
miR-34c belongs to a family of microRNAs that are induced by
p53 and cause cell cycle arrest and apoptosis, partially by
targeting the expression of c-MYC.24 This miRNA also regulates
multiple components of the WNT pathway, including β-catenin,
and acts as a tumour suppressor miRNA in many cell types.25
Restoration of miR-34c expression leads to a decrease in the
migration, invasion and metastatic potential of nasopharyngeal
carcinoma cell lines.26 Notably, miR-34c is expressed in oral
keratinocytes at much higher levels than in skin keratinocytes
(more than 150 times; results not shown). This difference indicates
that the functions exerted by this specific microRNA could be
more important in oral epithelia than in skin. More studies are
needed to determine whether the different effects of IKKβ on
tumoural transformation in oral and skin keratinocytes are
mediated by miR-34c.
The reduced level of miR-21 found in K5-IKKβ oral keratinocytes
is surprising, as this miRNA is considered to be oncogenic and is
overexpressed in many types of tumours. miR-203 is differentially
expressed in the epithelium and mesenchyme of dental primordia,
and hence, it could be important in tooth organogenesis.27 Thus,
the overexpression of miR-203 found in K5-IKKβ oral keratinocytes
could contribute to the development of ameloblastic odontomas
and secondary ameloblastic carcinomas observed in p53EKO/K5-
IKKβ and Ink4a/ArfKO/K5-IKKβ mice.
Under treatment with oral carcinogens, IKKβ promotes the
appearance of more oral tumoural lesions (and more malignant
lesions) in the palate and forestomach in a genetic background
prone to the development of epithelial cancers (TgAC mice).5
Interestingly, these mice do not develop odontogenic tumours. By
contrast, the cooperation of IKKβ overexpression with the lack of
tumour suppressor proteins (p53 or p16 and p19) leads to the
appearance of spontaneous ameloblastic odontomas in ~25% of
animals, indicating that although the overexpression of IKKβ
makes odontogenic epithelia prone to tumoural transformation, a
concomitant lack of tumour suppressor proteins is needed for
odontogenic tumour formation.
There are no published data regarding the genomic alterations
present in ameloblastic tumours in repositories of genomic data
for human cancers such as TCGA. Nevertheless, data available at
cBioportal indicate that the most mutated genes in head and neck
SCC include TP53 (71.5%) and CDKN2A (the human locus that
encodes p16 and p14, which is the human equivalent of murine
p19; 22.1%). The implication of CDKN2A in the pathogenesis of
odontogenic and other head and neck cancers is reinforced by the
characterization of CDKN2A as a susceptibility locus for nasophar-
yngeal carcinoma in a genome-wide association study performed
in a Chinese population;28 in addition, it has been suggested that
the methylation of the CDKN2A locus is an important mechanism
of odontogenic tumourigenesis,29,30 and loss of heterozygosity is
observed for both TP53 and 9p22-p21 (the genomic region where
the CDKN2A locus occurs) in odontogenic tumours.31
At present, it is uncertain which of the proteins encoded by the
CDKN2A locus needs to be lost to cooperate with IKKβ over-
expression in odontogenic tumour formation. Mice lacking both
p16 and p19 develop tumours, mainly sarcomas and lymphomas,
but not odontogenic tumours. Mice that are null for p19 (but not
for p16), generated by deleting exon E1β,32 develop tumours
similar to those observed in p16 and p19 double-null mice,
although a lack of p19 in association with Tax oncogene
expression has been implicated in osteosarcoma development.33
Wild-type keratinocytes of the oral epithelia express p16 at higher
levels than skin keratinocytes, suggesting that p16 loss could be
important in oral tumourigenesis. Nevertheless, the deletion of
either p16 or p19 individually in an animal model overexpressing
IKKβ would allow the specific role of these proteins in the
development of odontogenic tumours to be discerned.
β-catenin deserves particular attention as a possible driver of
odontoma formation, as WNT overactivity causes the develop-
ment of supernumerary teeth,10,11 and mice with increased WNT
activity in the oral epithelium develop odontomas.12 In addition,
β-catenin expression appears to increase with the aggressiveness
of odontogenic lesions, which also increases its nuclear localiza-
tion.34 Accordingly, through western blotting and immunohisto-
chemical analyses, we detected increased β-catenin levels and/or
activation in the ameloblastic odontomas of our animal models,
especially in the areas of secondary ameloblastic carcinoma.
Therefore, p53EKO/K5-IKKβ mice and Ink4a/Arf KO/K5-IKKβ mice
represent good models for studying the pathogenesis of the
progression to secondary ameloblastic carcinoma from pre-
existing ameloblastic odontoma and are also very useful for
testing the efficacy of IKKβ or WNT/β-catenin inhibitors in
preventing odontogenic tumour development.
In summary, our results show that IKKβ overactivity in oral and
odontogenic epithelia leads to changes in both the cellular
composition of the epithelia and the expression of several tumour
suppressor proteins and miRNAs that result in a preneoplastic state
of the cells. IKKβ overactivity in transgenic mice in conjunction with
the absence of tumour suppressor proteins (such as p53, p16 and/or
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p19) leads to the appearance of odontogenic tumours, which show
activation of the WNT/β-catenin pathway. Therefore, these results
indicate the possibility of treating ameloblastic odontomas with
pharmacologic inhibitors of IKKβ or WNT/β-catenin to prevent their
evolution to ameloblastic carcinoma.
MATERIALS AND METHODS
Mice and genotyping
All mouse husbandry and experimental procedures were
performed according to European and Spanish laws and regula-
tions and were approved by the local Animal Ethical Committee
and the competent authority (code PROEX 086/15).
The genotyping of K5-IKKβ, p53EKO/K5-IKKβ and Ink4a/Arf KO/K5-
IKKβmice was performed by PCR analysis of tail DNA as previously
described.35–38 K5-IKKβ mice are available from the European
Mouse Mutant Archive (code EM:09179). The expected genotypes
were obtained in roughly Mendelian rates in the different crosses.
Histology and immunohistochemistry
Mouse tissues were dissected, immediately fixed in 10% buffered
formalin or 70% ethanol, and embedded in paraffin. Five micron
thick sections were used for H&E staining or immunohistochem-
ical preparations. The antibodies used are listed in Supplementary
Table S1. Secondary antibodies were purchased from the Jackson
Immunoresearch Laboratory. Immunoreactivity was revealed
using an ABC-peroxidase system (Vector Laboratories), and the
sections were lightly counterstained with haematoxylin. Control
experiments omitting the primary antibody produced no signal.
Culture of oral keratinocytes
Epithelial and submucosal cells were harvested from the oral
tissue (inner cheek and palate) of 2-day-old K5-IKKβ and control
mice as described previously39 with minor modifications. The
samples were incubated overnight at 4 °C with 1 unit per mL
dispase (Sigma, P-3417); then, the oral epithelia were separated
and digested with trypsin (Gibco) for 15min at 37 °C. Keratino-
cytes were seeded in high-calcium medium [Ca2+-free and
Mg2+-free EMEM (BioWhittaker, Lonza, Switzerland) supplemented
with 4% Chelex-treated (Bio-Rad, Hercules, CA) foetal bovine
serum (Cultek, Madrid, Spain) and 0.2 mmol·L−1 Ca2+]. After
overnight culture for cell attachment, the dishes were washed
three times with cold PBS, and growth medium (CnT-24, Cellntec,
Switzerland) was added. Then, the keratinocytes were allowed to
grow to confluence. The keratinocytes were subjected to
consecutive passages at low dilution using high-calcium medium
for seeding. Cells that had undergone fewer than five passages
were used for western blot analysis.
For proliferation studies, cells were incubated with 10 µmol·L−1
BrdU for 1 h, and BrdU incorporation was detected by immunohis-
tochemistry. The detection of senescence was carried out by using a
senescence β-galactosidase staining kit (9860, Cell Signaling). In
colony-forming assays, growing colonies were fixed and stained with
Coomassie blue, and the number of colonies was counted.
Flow cytometry analysis of cell populations from oral epithelia
Epithelial keratinocytes and submucosal cells were harvested from
the oral tissue (hard and soft palate) of 9-week-old K5-IKKβ and
control mice and analysed as previously described for skin cells.7
Protein extraction and western blot analysis
Total protein extracts (30 μg) from cultured mouse oral keratinocytes,
tumours or tissues were prepared following standard techniques. The
antibodies used are listed in Supplementary Table S1.
RNA isolation and real-time PCR
Total RNA, including miRNA, was isolated from cell cultures from oral
tissue by using the miRNeasy Mini Kit (Qiagen) according to the
manufacturer’s instructions. The reverse transcription reaction was
performed by using the High-Capacity cDNA Reverse Transcription
Kit (Applied Biosystems) for mRNA and the TaqMan MicroRNA
Reverse Transcription Kit (Applied Biosystems) for miRNA. Quanti-
tative qRT-PCR was performed in a 7500 Fast Real-Time PCR System
using GoTaq qPCR Master Mix (Promega) for mRNA and TaqMan
Universal PCR Master Mix (Applied Biosystems) for miRNA. The
sequences of the oligonucleotides used are provided in.7 For miRNA,
TaqMan probes were used. TBP was used for the normalization of
mRNA expression, and SnoRNA202 and SnoRNA234 were used for
the normalization of miRNA expression.
CT analysis
CT studies were performed in a small-animal Argus PET-CT
scanner (SEDECAL, Madrid, Spain) in mice that were anaesthetized
by the inhalation of 2%–2.5% isoflurane in 100% oxygen, with the
following acquisition parameters: voltage 45 kV, current 150 μA,
8 shots, 360 projections and standard resolution.
Images were analysed using the image analysis software ITK-
SNAP.
Statistical analysis
For mRNA expression, BrdU incorporation, colony formation and
SA-β-galactosidase assays, p-values were determined by using the
unpaired, two-tailed Student’s t-test. For flow cytometry assays,
the Mann-Whitney test was used. All experiments were performed
at least three times. P < 0.05 were considered significant, and the
data were expressed as the mean ± SEM. For miRNA expression,
we employed REST 2009 Software (Qiagen), which calculates
statistical significance using bootstrapping and randomization
algorithms.40
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